CNS & Neurological Disorders-Drug Targets

Papers
(The H4-Index of CNS & Neurological Disorders-Drug Targets is 20. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Meet the Editorial Board Member70
Meet the Regional Editor65
The Potential Effect of Blueberry on Cognitive Health and Mood State based on Human Intervention Studies: Systematic Review and Mini Meta-Analysis47
Na+/HCO3− Co-transporters Inhibitor S0859 Attenuates Global Cerebral Ischemia-reperfusion Injury of the CA1 Neurons in the Gerbil’s Hippocampus43
Decoding the Inter-Relationship between Sleep Disorders and Alzheimer’s Disease Pathogenesis40
The Natural Neuroprotective Compounds Used in the 6-Hydroxydopamine- Induced Parkinson’s Disease in Zebrafish: The Current Applications and Perspectives37
Hypomyelination with Atrophy of Basal Ganglia and Cerebellum (HABC) Due to UFM1 Mutation in Roma Patients - Severe Early Encephalopathy with Stridor and Severe Hearing and Visual Impairment. A Single 31
Neurobiology of Amphetamine use in Stroke Recovery Combined with Rehabilitative Training and Brain Stimulation30
Memory Reflections of the Microbiota-Gut and Oligodendrocyte Axis29
Restless Leg Syndrome in Patients with Liver Cirrhosis! Its Frequency, Severity, and Correlation27
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment26
Drosophila melanogaster a Versatile Model of Parkinson’s Disease25
Effects of α7 Nicotinic Acetylcholine Receptor Positive Allosteric Modulator on BDNF, NKCC1 and KCC2 Expression in the Hippocampus following Lipopolysaccharide-Induced Allodynia and Hyperalgesia in a 22
Emerging Nanotechnology for the Treatment of Alzheimer’s Disease21
Monoamine Oxidase: A Potential Link in Papez Circuit to Generalized Anxiety Disorders21
Cholinesterase Inhibitory and In Silico Toxicity Assessment of Thirty-Four Isoquinoline Alkaloids - Berberine as the Lead Compound20
GFAP and UCHL1 in Non-traumatic SAH: The Story thus Far. A Systematic Review of the Literature20
Unraveling the Triad: A Bioinformatics Analysis of the Interplay between Prenatal Depression, Inflammation, and the Gut Microbiota20
The Emerging Role of Marine Natural Products for the Treatment of Parkinson’s Disease20
Unravelling the Role of Tyrosine and Tyrosine Hydroxylase in Parkinson’s Disease: Exploring Nanoparticle-based Gene Therapies20
0.096580982208252